Moreover, PIK3CB mutation and amplification is significantly enriched in tumors with FOXP1-SHQ1 deletion (P = 0.002, Fisher’s exact test) in the TCGA prostate cancer cohort, which has available exome sequencing data (Supplementary Table 1). The gene discussed is SHQ1; the disease is prostate cancer.